- Among adults with kidney failure who were referred for transplantation, 60% of black and 66% of white patients were waitlisted within the first year. Differences in socioeconomic status and comorbidities between black and white patients could explain up to 58% of the disparity in listing.
- Fewer black patients on transplant wait lists received transplants compared with white patients, but differences in socioeconomic status and comorbidities did not explain this disparity.
Newswise — Washington, DC (May 7, 2020) — Among adults with kidney failure in need of a transplant, socioeconomic status and medical illnesses likely contribute to racial disparities in being put on transplant wait lists. The findings come from a study that will appear in an upcoming issue of CJASN.
Black adults are more likely than white adults to develop kidney failure, and yet their odds of being listed for and receiving a kidney transplant are lower. To assess whether socioeconomic status and illnesses besides kidney disease (comorbidities) affect these disparities, Mara McAdams-DeMarco, PhD, Karly Murphy, MD, MHS (Johns Hopkins Medical Institutions), and their colleagues examined information on 3,013 patients with kidney failure who were referred for and who started the transplant process between 2009 and 2018.
“We examined socioeconomic status—using income, education level, and employment status—and 17 medical comorbidities as potential mediators, both individually and combined, to explain racial disparities in listing for kidney transplant or for receiving a kidney transplant,” said Dr. McAdams-DeMarco.
The team found that within the first year, 60% of black and 66% of white patients were waitlisted. Differences in socioeconomic status explained 36% of the disparity in listing, while differences in comorbidities explained 44% of the disparity in listing. Together, differences in socioeconomic status and comorbidities between black and white patients could explain up to 58% of the disparity in listing.
Among 2,109 listed candidates, transplants occurred at rates of 19 and 24 per 100 persons per year for black and white candidates, respectively. Differences in socioeconomic status and comorbidities did not explain the disparities in receipt of transplants between black and white transplant candidates.
“We found that socioeconomic status and medical history most likely influence the likelihood that a person would be listed for transplant but did not change the likelihood of receiving a kidney transplant,” said Dr. McAdams-DeMarco.
Study co-authors include John W. Jackson, ScD, Tanjala S. Purnell, PhD, MPH, Ashton A. Shaffer, BA, Christine E. Haugen, MD, Nadia M. Chu, PhD, MPH, Deidra C. Crews, MD, ScM, Silas P. Norman, MD, and Dorry L. Segev, MD, PhD.
Disclosures: Dr. Segev reports funding from CSI, Behring, Novartis, and Sanofi, outside this work. The authors reported no conflicts of interest relevant to this research.
The article, entitled “Association of Socioeconomic Status and Comorbidities with Racial Disparities During Kidney Transplant Evaluation,” will appear online at http://cjasn.asnjournals.org/ on May 7, 2020, doi: 10.2215/CJN.12541019.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit www.asn-online.org.
# # #
MEDIA CONTACTRegister for reporter access to contact details